Hyung Joon Kim

Hyung Joon Kim

Auto-generated profile, based on publicly available information

Hyung Joon Kim

Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in European Urology Focus
Verified
Journal Article
Closed access
HKHyung Joon Kim
Hyung Joon Kim
SDStephanie Daignault-Newton
Stephanie Daignault-Newton
JDJohn Michael DiBianco
John Michael DiBianco
BCBronson Conrado
Bronson Conrado
SJS. Mohammad Jafri
S. Mohammad Jafri
KGKhurshid R. Ghani
Khurshid R. Ghani

1 January 2015 in Korean Journal of Urology
Verified
Journal Article
Open access
PDF file
YMYoung Joon Moon
Young Joon Moon
HKHong-Wook Kim
Hong-Wook Kim
JKJin Bum Kim
Jin Bum Kim
HKHyung Joon Kim
Hyung Joon Kim
YCYoung-Seop Chang
Young-Seop Chang
Moon YJ, et al. Korean J Urol. 2015 Oct;56(10):717-721. https://doi.org/10.4111/kju.2015.56.10.717

19 August 2022 in European Urology Open Science
Verified
Journal Article
Open access
HKHyung Joon Kim
Hyung Joon Kim
KGKhurshid R. Ghani
Khurshid R. Ghani

16 June 2023 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
Hae Do JungHae Do Jung
Hae Do Jung
Joo Yong LeeJoo Yong Lee
Joo Yong Lee
DKDong Hyuk Kang
Dong Hyuk Kang
KKKyungtae Ko
Kyungtae Ko
DKDong Hoon Koh
Dong Hoon Koh
HKHyung Joon Kim
Hyung Joon Kim
Jung HD, et al. Investig Clin Urol. 2023 Jun;64:e45. https://doi.org/10.4111/icu.20230102

1 January 2020 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
HKHyung Joon Kim
Hyung Joon Kim
MGMi Kyung Gong
Mi Kyung Gong
CYCheol Yong Yoon
Cheol Yong Yoon
Jaeku KangJaeku Kang
Jaeku Kang
MYMijin Yun
Mijin Yun
YCYoung Deuk Choi
Young Deuk Choi
Kim HJ, et al. Yonsei Med J. 2020 Jul;61(7):587-596. https://doi.org/10.3349/ymj.2020.61.7.587

24 June 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
HKHo Won Kang
Ho Won Kang
SYSeok Joong Yun
Seok Joong Yun
JCJae Il Chung
Jae Il Chung
HCHoon Choi
Hoon Choi
JKJae Heon Kim
Jae Heon Kim
SKSo Young Kim
So Young Kim
Background: A complete enumeration study was conducted to evaluate trends in national practice patterns and direct medical costs for prostate cancer (PCa) in Korea over a 10-year retrospective period using data from the Korean National Health Insurance Service. Methods: Reimbursement records for 874,924 patients diagnosed between 2002 and 2014 with primary PCa according to the International Classification of Disease (ICD) 10th revision code C61 were accessed. To assess direct medical costs for patients newly diagnosed after 2005, data from 68,596 patients managed between January 2005 and 31 December 2014 were evaluated. Results: From 2005 to 2014, the total number of PCa patients showed a 2.6-fold increase. Surgery and androgen deprivation therapy were the most common first-line treatment, alone or within the context of combined therapy. Surgery as a monotherapy was performed in 23.5% of patients in 2005, and in 39.4% of patients in 2014. From 2008, the rate of robot-assisted RP rose sharply, showing a similar rate to open RP in 2014. Average total treatment costs in the 12 months post-diagnosis were around 10 million Korean won. Average annual treatment costs thereafter were around 5 million Korean won. Out-of-pocket expenditure was highest in the first year post-diagnosis, and ranged from 12 to 17% thereafter. Conclusions: Between 2005 and 2014, a substantial change was observed in the national practice pattern for PCa in Korea. The present data provide a reliable overview of treatment patterns and medical costs for PCa in Korea.